Fin Cascade
Get Android appGet iOS app

Prices as of 8 Oct 2026 close · Not investment advice

Fineotex Chemical Limited

NSE: FCLSpecialty Chemicals

Share price

₹55.99

-3.13% close of 8 Oct 2026

Market cap ₹6,495 CrP/E 53.2

Business score

How strong the business is, in one number. The parts behind it are in Pro.

62

out of 100 · worked out 8 Oct 2026

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹6,495 Cr

P/E ratio

53.2

P/B ratio

7.4

ROCE

18.3%

ROE

13.5%

Dividend yield

0.2%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 8 Oct 2026 close52-week high ₹60.4852-week low ₹19.24

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Sales grew 91.4% over the past year, and 23.7% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales slipped from 19.9% to 17.8% over the last four years.

Whether it grew faster than its sector

It grew 23.7% a year against a sector median of 10.2% — 13.5 percentage points faster.

Room to re-rate, or risk of de-rating

At 53.2× earnings it costs 2.2× the market, which pays 23.9× across 2199 companies we can price. Its own industry sits at 56.2×, across 5 companies. It is against its own five-year median of 36.0×, the 95th percentile of its own range.

Whether growth justifies the valuation

Priced at 7.6 times its growth rate, on earnings growth of 7%.

Profit growthPrice per ₹1 profitPer 1% growth
Fineotex Chemical Limited — this one7%/yr53.2×₹7.6
Pidilite Industries25%/yr56.2×₹2.2
Gujarat Fluorochemicals Limited-24%/yr79.0×—
Navin Fluorine International Limited21%/yr53.0×₹2.5
Aether Industries Limited20%/yr96.7×₹4.8
Deepak Nitrite Limited-13%/yr27.0×—

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Specialty Chemicals), it ranks 20 of 73 on returns, 6 of 72 on growth, 23 of 73 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

A narrow advantage: it earns 18.3% on capital, ahead of 73% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

Yes — Over the last five years it made ₹262 crore of cash from the business and spent ₹182 crore on plant and equipment, with ₹80 crore to spare; it still raised ₹77 crore from lenders and shareholders. And the profit is real: of every 100 rupees it reported over 12 years, about 54 arrived as cash. Its cash comes back more slowly than it used to: it went from being waiting 125 days for its cash to waiting 140 days for its cash.

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

8 of 9 checks clear · 89%

Latest result · Q1 FY27

What the last results showed. Whether management kept its word is in Pro.

Revenue rose 175% year over year, while net profit rose 93%.

Announced 23 Jul 2026 · Consolidated · Unaudited

Revenue

₹377 Cr

Revenue vs last year

+174.8%

Revenue vs last quarter

+20.0%

Net profit

₹48 Cr

Profit vs last year

+92.8%

Profit vs last quarter

+9.6%

Net margin

12.8%

EPS

₹0.41

Earnings call transcript · 24 Jul 2026

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹6,495 Cr
Prev close
₹55.99
52w High
₹62.4
52w Low
₹19.1
Enterprise value
₹6,482 Cr
Beta
1.5
Price CAGR 1y
137.0%
Price CAGR 3y
23.0%
Price CAGR 5y
35.0%
Price CAGR 10y
35.0%

Ratios

Return on assets
10.8%
PEG ratio
7.6
P/E ratio
53.2
P/B ratio
7.4
EV / EBITDA
48.4
Industry P/E
32.7
ROCE
18.3%
ROCE 5y average
29.4%
ROE
13.5%
Debt / Equity
0.0
Interest coverage
154.0
Dividend yield
0.2%
ROE 3y average
19.0%
ROE last year
13.0%

Annual P&L

Annual revenue
₹772 Cr
Annual profit
₹125 Cr
Operating margin
17.0%
Net profit margin
16.2%
EBITDA margin
17.5%
Sales growth 3y
14.3%
Sales growth 5y
28.7%
Profit growth 3y
7.0%
Profit growth 5y
21.0%
EPS
₹0.9
Sales growth TTM
91.0%
Profit growth TTM
17.0%
Dividend payout
48.0%

Quarter P&L

Sales latest quarter
₹377 Cr
Profit latest quarter
₹48 Cr
YoY quarterly sales growth
174.8%
YoY quarterly profit growth
92.0%
OPM latest quarter
15.7%

Balance Sheet

Book Value
₹7.6
Face Value
₹1.0
Total debt
₹8 Cr
Total cash
₹46 Cr
Borrowings
₹8 Cr
Reserves / Equity
6.6

Cash Flow

Operating cash flow
-₹24 Cr
Free cash flow
-₹40 Cr
FCF yield
-0.6%
Net cash flow
₹27 Cr

Shareholding

Promoter holding
62.3%
FII holding
3.2%
DII holding
1.4%
Public holding
33.2%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
Pidilite Inds.1,488.5057.21,51,6100.77883.528.24,551.621.331.0
Gujarat Fluoroch4,555.9081.050,0470.07219.021.41,588.024.09.6
Navin Fluo.Intl.8,490.0054.843,5660.18243.3107.71,045.144.121.0
Aether Industri.1,787.6098.923,7270.0062.828.0326.627.311.9
Deepak Nitrite1,553.9026.821,1940.48345.0207.52,577.636.411.4
Aarti Industries491.2534.117,8200.20155.0256.52,387.042.56.9
Atul5,999.5022.217,6640.50253.992.01,848.025.014.9
Fineotex Chem57.8055.06,7310.2248.254.8376.6174.818.3
Median367.3029.71,1020.2413.552.2175.326.413.8

Competes with: Aarti Industries Limited, Aether Industries Limited, Atul Limited, BASF India Limited, Deepak Nitrite Limited, Gujarat Fluorochemicals Limited, Navin Fluorine International Limited, Pidilite Industries

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Consolidated · to 30 Jun 2026
Line itemJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales132145138153142146126120137138184314377
Expenses101107981151071099299112107149270317
Material Cost838388117225248
Change in Inventories-2.71-0.20-6.20-3.57-3.15-5.09
Purchases of Stock-in-Trade-4.398.562.616.030.920
Employee Cost6.556.206.52101727
Other Expenses161515203047
Operating Profit32384038353634212531354459
OPM %24262925252527181823191416
Other Income44545758987910
Exceptional items (within Other Income)000000
Interest0001000000010
Depreciation1112223233344
Profit before tax34404440384136263135384865
Tax %2222242422212424212621926
Net Profit26313330293228202526304448
EPS in Rs0.230.280.290.270.260.280.240.170.220.230.230.270.33
Diluted EPS in Rs1.762.182.270.260.380.41

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Consolidated · to 31 Mar 2026
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1021101271411821962193685175695337721,012
Expenses858298111148162178297404421406637843
Material Cost339512
Change in Inventories-14-13
Purchases of Stock-in-Trade2.9518
Employee Cost2440
Other Expenses5480
Operating Profit1628293034354171113148127135169
OPM %16262321191819192226241717
Other Income521051-11176717243334
Exceptional items (within Other Income)00
Interest00011111111.071.361
Depreciation0111111346.029.221315
Profit before tax2029383434225673115158141153186
Tax %283124292835202222232318
Net Profit152029242414455790121109125148
EPS in Rs0.110.160.230.200.200.120.380.500.801.080.940.931.06
Diluted EPS in Rs9.531.09
Dividend Payout %91341054881015848

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
22%
5 years
29%
3 years
14%
TTM
91%

Compounded profit growth

10 years
20%
5 years
21%
3 years
7%
TTM
17%

Stock price CAGR

10 years
35%
5 years
35%
3 years
23%
1 year
137%

Return on equity

10 years
20%
5 years
21%
3 years
19%
Last year
13%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital2222222222222222222223116
Reserves546990113137147187240327425708766
Borrowings231523327508
Other Liabilities2320262134355475679683269
Minority Interest7.5557
Total Liabilities1011141401611952082673394235488151,159
Fixed Assets181927293641598499141179278
CWIP0000015000212
Investments293947554852321789147330317
Other Assets54566677110114171238234260284562
Total Assets1011141401611952082673394235488151,159

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity141419612289131079769-24
Cash from Investing Activity-14-13-14-65-19-71-99-47-273113
Cash from Financing Activity-3-1-6-4-3-4-4-6-6-24176-63
Net Cash Flow-3-1-1-3146-28126-2727
Free Cash Flow812144422-15-98849-7.68-40

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days8084847298100138110728979137
Inventory Days5666709784667998535575112
Days Payable75758250707310196537966117
Cash Conversion Cycle60757211911293116111726488133
Working Capital Days5873731141181071361257176104140
ROCE %213135262220283036392418

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Consolidated · to 30 Jun 2026
Line itemSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters656565646363636363636262
FIIs0.720.821.450.923.283.362.842.512.352.532.923.16
DIIs3.863.693.703.683.633.613.713.171.631.281.271.35
Public303030313030313133343433
No. of Shareholders1,16,8011,16,0671,22,0951,26,6731,28,2681,29,0681,33,8991,36,8421,46,5221,64,4661,62,2761,80,711

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year +133.4% (₹23.99 → ₹55.99)Brick size ₹3.39 (fixed)Bricks 16
₹20.00₹40.00₹55.99Nov '25Jun '26
Price moved up one brickPrice moved down one brickLast close ₹55.99 on 8 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

exports as % of revenue

77.00

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

FY revenue / permanent employees + workers, same basis (calc)

1,85,45,715inr

2026-03-31

News

News and filings about Fineotex Chemical Limited. Open one to see why it matters.

No recent news for this company.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Competes with

Uses as raw material

  • enzymes
  • silicones and high-end finishing performance-chemical intermediates
  • specialty oilfield chemical additives and fluids (CrudeChem oil & gas segment)
  • surfactant and polymer intermediates (polymerisation, esterification, phosphonation, sulphonation)

Sells to

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Chemicals
Industry
Specialty Chemicals
Classification
Chemicals › Specialty Chemicals
ISIN
INE045J01034

Plants

  • Biotex Malaysia Chemicals Facility
  • CrudeChem Technologies Facility
  • Fineotex Ambernath Plant - B-24 Additional MIDC
  • Fineotex Ambernath Plant - Chikhloli MIDC
  • Fineotex Mahape Facility

News impact

Big market events that reach Fineotex Chemical Limited, and how the effect spreads.

23 Sept, 07:38 IST · Market event · medium impact

India starts anti-dumping probe into Chinese Glycine imports

India is probing cheap Chinese glycine imports, which could help home chemical makers later but may raise costs for food, drug and farm buyers if an import tax follows.

Chemicals

Who it hits first

  • India's trade investigator (DGTR, the body that checks unfair imports) opened a probe into cheap glycine, a simple chemical used in food, drugs and farm sprays, arriving from China.
  • If the probe finds harm to local makers, India can add an import tax (anti-dumping duty) that makes Chinese glycine costlier and helps home producers sell more.
  • No listed glycine maker is named in the evidence, so any stock lift today is hope of future protection, while buyers of glycine could later pay more.

Who may gain

  • Indian glycine and nearby specialty makers, if a duty lifts local prices (no single listed maker confirmed in the pack)
  • Farm-chemical sellers such as PI Industries and GSP Crop, if protection spreads to agro inputs

Along the supply chain

Downstream

Indian food, drug and farm-spray makers that buy glycine could face higher input costs if cheap Chinese supply is taxed.

Upstream

Chinese glycine exporters face the probe; if a duty follows, their shipments to India shrink.

Where demand moves

Business

No extra orders yet — the probe only starts the case; real business gain comes months later if a duty curbs Chinese supply and buyers switch to home makers.

Capital

No fresh funds flow; investors may bid up chemical shares on protection hopes, but cash gains arrive only if duties lift prices and profits.

How it spreads across sectors

Chemicals

Small positive mood for home makers on protection hopes; real gains only if a duty lands.

Pharma

Mild cost worry since glycine feeds drugs; dearer supply would squeeze pill makers later.

Textiles

Negligible near-term link; fibre makers watch only for broader China-duty mood.

A pattern seen before

Cascade chain

  • DGTR probes Chinese glycine dumping → possible import duty
  • Duty curbs cheap imports → domestic glycine prices firm
  • Chemical makers gain share → pharma and textile buyers face higher costs

Pattern name

China Cascade

Patterns

  • China Cascade

Sectors queried

  • Pharma
  • Textiles

When it plays out

Immediate

1–7 days: chemical shares drift on protection hopes with no order change.

Medium term

1–6 months: probe findings decide any duty; only then do prices, orders and margins move.

Short term

1–4 weeks: filings and hearing news set expectations; buyers watch for price hints.

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Dividends

4 Sep 2026unspecified₹0.05
31 Oct 2025split₹0
31 Oct 2025bonus₹0
3 Oct 2025interim₹0.8
12 Sep 2025unspecified₹0.4
18 Feb 2025interim₹0.4
3 Sep 2024unspecified₹0.4
26 Feb 2024interim₹1.2

Splits, bonuses & buybacks

  • daily-prices repair: 10 rows from NSE's archive (replace 2, delete 1, insert 7), 2016-02-12..2026-02-01 (docs/flat_day_repair.md)1× · 12 Feb 2016

Bulk & block deals

DateWhoBought / soldSharesPrice
25 May 2026JUNOMONETA FINSOL PRIVATE LIMITEDBUY82,18,146₹37.02
25 May 2026JUNOMONETA FINSOL PRIVATE LIMITEDSELL81,99,269₹37.04
25 May 2026HRTI PRIVATE LIMITEDSELL75,24,208₹36.80
25 May 2026HRTI PRIVATE LIMITEDBUY69,46,778₹36.60
20 May 2026JUNOMONETA FINSOL PRIVATE LIMITEDSELL60,77,450₹34.39
20 May 2026JUNOMONETA FINSOL PRIVATE LIMITEDBUY60,26,180₹34.37
20 May 2026QE SECURITIES LLPSELL59,77,023₹34.29
20 May 2026QE SECURITIES LLPBUY58,73,356₹34.42
19 May 2026NK SECURITIES RESEARCH PRIVATE LIMITEDSELL90,03,028₹33.04
19 May 2026NK SECURITIES RESEARCH PRIVATE LIMITEDBUY90,03,028₹33.03

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.